| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |